Recent Blog Articles

Corneal transplants becoming more common

An emerging treatment option for men on active surveillance

Gun violence: A long-lasting toll on children and teens

Adult female acne: Why it happens and the emotional toll

Talking to your doctor about your LGBTQ+ sex life

Untangling grief: Living beyond a great loss

Thunderstorm asthma: Bad weather, allergies, and asthma attacks

Heart problems and the heat: What to know and do

I’m too young to have Alzheimer’s disease or dementia, right?

Period equity: What it is and why it matters

Charlie Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
Charlie Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for Harvard Health Publishing, Charlie has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by Charlie Schmidt

Men's Health
An emerging treatment option for men on active surveillance

Men's Health
Some men whose prostate cancer progresses can safely delay treatment

Men's Health
New treatment approved for late-stage prostate cancer

Men's Health
Comparing traditional and robotic-assisted surgery for prostate cancer

Men's Health
Treatment with abiraterone significantly improves survival in advanced prostate cancer

Men's Health
New study investigates treatment-associated regrets in prostate cancer

Men's Health
Acupuncture relieves prostatitis symptoms in study

Men's Health
Recent study shows more complications with alternative prostate biopsy method

Men's Health
Study: No effect on cognitive functioning from treatments for advanced prostate cancer

Men's Health
Cardiovascular safety from prostate cancer drugs remains uncertain

Men's Health
Level of health literacy affects treatment choice for slow-growing prostate cancer

Men's Health
A new treatment for advanced prostate cancer improves survival in phase 3 clinical trial

Men's Health
Large review study finds low risk of erectile dysfunction after prostate biopsy

Men's Health
American Heart Association issues statement on cardiovascular side effects from hormonal therapy for prostate cancer

Charlie Schmidt
An emerging treatment option for men with recurring prostate cancer after radiation therapy

Charlie Schmidt
Improving PET scans are good news for doctors and patients alike

Charlie Schmidt
Hormonal therapies for advanced prostate cancer linked to a higher risk of falls and fractures

Charlie Schmidt
New high-resolution imaging scans approved for use in prostate cancer

Charlie Schmidt
The sequence of hormonal therapy and radiation affects outcomes in men treated for prostate cancer
Charlie Schmidt
New online model identifies which men can have fewer biopsies on active surveillance
Charlie Schmidt
Hormonal treatments for prostate cancer may prevent or limit COVID-19 symptoms
Charlie Schmidt
Hormonal treatments for prostate cancer are often given late
Charlie Schmidt
A new hormonal therapy for prostate cancer is under expedited FDA review
Charlie Schmidt